There are four molecular subtypes (Luminal A, Luminal B, Her2 and triple negative) of breast cancer (BC), determined by the expression of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (Her2) and Ki-67. This evidence concerns the gene ERBB2 and breast cancer.